UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-2 of 2 Help

Filters                
Selected(0)Clear Items/Page:    Sort:
Development and validation of an HPLC-DAD method for bis(12)-hupyridone and its application to a pharmacokinetic study Journal article
Journal of Pharmaceutical and Biomedical Analysis, 2009,Volume: 49,Issue: 2,Page: 410
Authors:  Yu H.;  Li W.M.;  Cheung M.C.;  Zuo Z.;  Carlier P.R.;  Gu Z.M.;  Chan K.;  Huang M.;  Wang Y.T.;  Han Y.F.
Favorite  |  View/Download:21/0  |  Submit date:2018/10/31
Alzheimer's Disease  Bis(12)-hupyridone  Hplc-dad  Pharmacokinetics  
The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine Journal article
Journal of Pharmaceutical and Biomedical Analysis, 2008,Volume: 46,Issue: 1,Page: 75
Authors:  Yu H.;  Li W.-M.;  Kan K.K.W.;  Ho J.M.K.;  Carlier P.R.;  Pang Y.-P.;  Gu Z.-M.;  Zhong Z.;  Chan K.;  Wang Y.-T.;  Han Y.-F.
Favorite  |  View/Download:9/0  |  Submit date:2018/10/30
Ache Inhibition  Bis(12)-hupyridone  Bis(7)-tacrine  Dimer  Ionization Constant  Lipophilicity  Solubility